This report provides the first-ever comparative analysis of the role and performance of private health insurance (PHI) in OECD countries. It analyses PHI markets and identifies policy issues arising from their interdependence with publicly financed health coverage schemes. The report assesses...

The importance of having access to care options and being able to finance this has been laid bare through the experience of the COVID-19 health emergency. While most countries have public options for long-term care and health care, these are not always comprehensive and may not support the needs...

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for...

This report, based on a series of initial interviews, and augmented by an extensive survey to which 25 countries in total responded, describes policies and practices adopted by countries to address a number of challenges that are specific to oncology medicines.

Under the Paris Agreement, OECD countries agreed to aim for a reduction of their greenhouse gas emissions sufficient to hold the increase in the global average temperature to well below 2°C above pre industrial levels. This commitment requires a massive effort to decarbonise energy and...